
4519.T-17.75%23.6%

ALNY-52.34%23.6%

ARWR+91.03%23.6%

WVE-42.24%23.6%

2257.HK-75.11%4.7%

NVO-36.52%1.0%
As of Oct 2, 2026, 9:55 PM ET
GLP-1 Long '26: RNA Fat Redistribution Constituents
Alnylam Pharmaceuticals, Inc.ALNY | 23.6% | -4.96% | -12.70% | -17.84% | -4.97% | -44.75% | -34.01% | -17.66% | -52.34% | -18.48% | 14.03% | $29.40B |
Arrowhead Pharmaceuticals, Inc.ARWR | 23.6% | -0.93% | -8.02% | -22.58% | 2.01% | -0.44% | 4.46% | 420.84% | 91.03% | 240.53% | 2.54% | $9.04B |
Chugai Pharmaceutical Co., Ltd.4519.T | 23.6% | -2.32% | -10.87% | -11.29% | -2.32% | -27.62% | -42.94% | -14.73% | -17.75% | -19.55% | 3.32% | $62.84B |
Wave Life Sciences Ltd.WVE | 23.6% | -2.58% | -6.78% | -16.91% | 4.51% | -76.15% | -70.89% | -46.43% | -42.24% | -55.53% | -21.25% | $744.8M |
Sirnaomics Ltd.2257.HK | 4.7% | -1.45% | 1.72% | -4.99% | -1.45% | -51.58% | -46.34% | 7.66% | -75.11% | -11.77% | -95.23% | $52.0M |
Novo Nordisk A/SNVO | 1.0% | -0.21% | -5.36% | -20.27% | -0.29% | -26.71% | -0.43% | -45.35% | -36.52% | -67.57% | -19.11% | $165.72B |
| Theme return | — | -2.61% | -9.02% | -17.18% | -1.42% | -38.84% | -36.53% | 29.68% | -21.02% | 13.76% | 49.81% | — |
| Average | 16.7% | -2.07% | -7.00% | -15.65% | -0.42% | -37.87% | -31.69% | 50.72% | -22.15% | 11.27% | -19.28% | $44.63B |
| Median | 23.6% | -1.88% | -7.40% | -17.37% | -0.87% | -36.18% | -38.47% | -16.19% | -39.38% | -19.02% | -8.28% | $19.22B |
| Std Dev | 9.8% | 1.52% | 4.61% | 5.89% | 3.04% | 23.56% | 26.35% | 166.57% | 53.47% | 104.57% | 36.22% | $58.32B |
| Min | 1.0% | -4.96% | -12.70% | -22.58% | -4.97% | -76.15% | -70.89% | -46.43% | -75.11% | -67.57% | -95.23% | $52.0M |
| Max | 23.6% | -0.21% | 1.72% | -4.99% | 4.51% | -0.44% | 4.46% | 420.84% | 91.03% | 240.53% | 14.03% | $165.72B |
| % Positive Tickers | 0.00% | 16.67% | 0.00% | 33.33% | 0.00% | 16.67% | 33.33% | 16.67% | 16.67% | 50.00% |